Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Clinical trial NCT01562678 · COMPLETED

Trial details

NCT number: NCT01562678
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Effects of Liraglutide Administration on Brain Activity Weight Loss Hunger

Start date: 2012-03-01
Primary completion: 2014-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.